MANF has also shown protective effects on a mouse model of multiple sclerosis, where recombinant MANF-treated mice showed less motor deficits compared to vehicle-treated mice in an early time-point after experimental autoimmune encephalomyelitis induction (Nam et al., 2021). Here, MANF is linked to multiple sclerosis.